🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the efficacy and safety of sitravat...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-06-30
Trial ID
NCT05564338
Treatments Being Tested
SITISVEAL stablish the hypothesis that treatment with Tislelizumab + Sitrav...
Status
Completed
Location
Hospital Universitario Virgen de la Macarena
Start Date
2022-09-23
Trial ID
NCT05542342
Treatments Being Tested
This is an open label, multi-center, single arm study to evaluate the effic...
Status
Unknown
Location
Anhui province hospital
Start Date
2022-07-25
Trial ID
NCT05407519
Treatments Being Tested
This is open-label, phase II study enrolling advanced BTC patients who have...
Status
Unknown
Location
Seoul National University Hospital
Start Date
2020-11-01
Trial ID
NCT04727996
Treatments Being Tested
This is an open-label, multicenter, extension study to evaluate the long-te...
Status
Completed
Location
Mount Sinai Medical Center Braman Comprehensive Cancer Center
Start Date
2019-12-19
Trial ID
NCT04164199
This study aims to evaluate the 1-year progression free survival (PFS) rate...
Status
Terminated
Location
Fudan University Shanghai Cancer Center
Start Date
2021-01-10
Trial ID
NCT05176925
Treatments Being Tested
The study aimed to evaluate the efficacy and safety of sitravatinib in comb...
Status
Terminated
Location
Anhui Provincial Hospital South Brance
Start Date
2022-10-03
Trial ID
NCT05461794
Treatments Being Tested
This was an open-label, multicenter, non-randomized Phase 1b clinical trial...
Status
Completed
Location
Blacktown Cancer and Haematology Centre
Start Date
2018-11-01
Trial ID
NCT03666143
Treatments Being Tested
This is an open-label, single-arm, prospective phase 2 study, evaluating th...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2022-03-17
Trial ID
NCT05228496
Treatments Being Tested
The purpose of this study was to evaluate the safety, tolerability, pharmac...
Status
Completed
Location
The Second Hospital of Anhui Medical University
Start Date
2019-02-28
Trial ID
NCT03941873
Treatments Being Tested